Figure 1. Coomassie-stained SDS-PAGE analysis of monoclonal antibody to SARS-CoV-2 Spike RBD, clone 6G7. 4-12% gradient gel is used for analysis. Lane 1. Monoclonal antibody to SARS-CoV-2 Spike RBD, clone 6G7 (-DTT). Lane 2. Size marker. Lane 3. Monoclonal antibody to SARS-CoV-2 Spike RBD, clone 6G7 (+DTT). Lane 4. Size marker.
Figure 2. HPLC analytical SEC for final product.
Figure 3. HPLC analytical SEC after 3 freeze-thaw cycles.
Figure 4. Octet RED96e analysis, antibody was loaded on sensor for capture of Spike S1 protein in different concentrations: 200 nM, 100 nM and 50 nM.
Human IgG1-kappa antibody to SARS CoV-2 S1 RBD (clone 6G7)
SARS-CoV-2 virus (PBMCs isolated from patients recovered from SARS-CoV-2 infection, antibodies discovered by using HybriFree Technology).
SARS-CoV-2 Spike RBD
Neutralizing properties: blocks S1 and ACE2 binding in Octet system; IC50 5000 ng/ml measured in live virus neutralization assay
Dissociation constant (KD)
< 1.0 x 10-12 M (measured against SARS-CoV-2 Trimeric Spike protein)
1.66 x 10-8 M (measured against SARS-CoV-2 Spike S1 protein)
Protein A affinity chromatography following desalting
PBS pH 7.4
Shipped at ambient temperature.
Store at +4 °C. Avoid multiple freeze-thaw cycles.
This product is for research use only
Please refer any technical questions email@example.com